Bibliografische Daten
ISBN/EAN: 9783034806633
Sprache: Englisch
Umfang: xxii, 199 S., 54 s/w Illustr., 199 p. 54 illus.
Format (T/L/B): 1.7 x 24.5 x 16 cm
Einband: gebundenes Buch
Beschreibung
Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. This monograph, written by V. Craig Jordan, the "Father of tamoxifen," and his team at Georgetown University illustrates the journey of this milestone in medicine.
Produktsicherheitsverordnung
Hersteller:
Springer Verlag GmbH
juergen.hartmann@springer.com
Tiergartenstr. 17
DE 69121 Heidelberg
Autorenportrait
InhaltsangabeDiscovery and Pharmacology of Nonsteroidal Estrogens and Antiestrogens.- Tamoxifen Goes Forward Alone.- Metabolites of Tamoxifen as the Basis of Drug Development.- Adjuvant Therapy - The Breakthrough.- The Wisconsin Story in the 1980's: Discovery of Target Site Specific Estrogen Action.- Carcinogenesis and Tamoxifen.- Chemoprevention: Cinderella waiting for the ball.- Tamoxifen and Raloxifene head to head: The STAR TRIAL.- Acquired resistance to Tamoxifen: back to the beginning.- The legacy of Tamoxifen.- Appendix: Four decades of discovery in breast cancer research and treatment - an interview with V. Craig Jordan by Marc Poirot.- Selected Awards that Recognize the Contribution of Tamoxifen and Raloxifene to Medicine.
